drugset / Trial / NCT03289403

The Role of Immunomodulatory Treatment in Success of ICSI in Patients With Autoimmune Thyroiditis

NCT03289403

Phase 2 Completed 194 enrolled Aljazeera Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of the work is to determine whether the use of immunomodulatory drugs could improve the reproductive of outcome of infertile patients who have autoimmune thyroiditis with positive autoimmune antibodies undergoing IVF-ET.

Timeline

Start
2018-03-07
Primary completion
2023-09-15
Completion
2024-01-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Azathioprine Small molecule
Subject Hydroxychloroquine Small molecule
Subject Immunoglobulins Protein / enzyme biologic Intravenous
Subject Prednisnlone Unknown 5 mg
Comparator Levothyroxine Other / unclassified